Result Summary for 580299/002
| Protocol ID: | 580299/002 |
| Clinical Study ID: | 580299-002 (HPV-002 [Mi-CP-044]) |
| Official Title: | A Phase I Study of the Safety and Immunogenicity of MEDI-517, a Vaccine Against Human Papillomavirus Types 16 and 18, in Healthy Adult Female Volunteers. |
| Phase: | Phase 1 |
| Study Indications or Diseases: |
|
| Generic Name: | Human Papillomavirus Types 16 and 18 Vaccine |
| Trade/Product Name: | Cervarix;Cervarix |
| Approved Drug Label: | http://www.gsk.com/products.html |
| Results Summary: |  Click
here to download result summary. |
| Citations: |
|
The summaries are in PDF format. If you do not have Adobe® Acrobat® Reader™ installed, you can download it for free.
